Pharmacopeia, Mitsubishi Chemical Co. Ltd., Teijin Ltd. deal

PCOP paid Teijin $10 million for the 50 percent of the Teijin Molecular Simulations Inc. joint venture it did not already own. The joint venture, which was the distributor in Japan and Asia for the s...